Role of patients' organizations in Health Technology Assessment: a Habermasian system and lifeworld perspective

被引:1
|
作者
Milevska-Kostova, Neda [1 ,2 ]
Duddi, Sita Ratna Devi [2 ,3 ]
Cooper, Richard J. [4 ]
机构
[1] Inst Social Innovat, Nikoia Parapunov 41, Skopje 1000, North Macedonia
[2] Int Alliance Patients Org, London, England
[3] Indian Alliance Patient Grp, Gurgaon, India
[4] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England
关键词
Technology assessment; Biomedical; Patient participation; Communication; Policy; Health resources; Social theory;
D O I
10.1017/S0266462320002147
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Patient and public involvement in Health Technology Assessment (HTA) is gaining increased interest among research and policy communities. Patients' organizations represent an important link between individual patients and the health system. Social theories are increasingly being used to explain doctor-patient-system interactions, expanding understanding beyond the mere clinical perspective. In this sense, patient involvement in HTA can also be considered through the Habermas's theory of communicative action. From a Habermasian perspective, HTA as part of the instrumental rationality contributes to an increased efficiency of resource use within the system; however, such rationalization threatens to colonize the lifeworld by making it "increasingly state administered with attenuated possibilities for communicative action as a result of the commercialization and rationalization in terms of immediate returns." Using Habermasian system/lifeworld framework, this paper explores opportunities and obstacles to patient involvement in HTA, whereby trying to understand current and possible roles of patients' organizations as a mediating force between HTA as a function of the system and the lifeworld represented by patients.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] PERSPECTIVE OF HEALTH TECHNOLOGY ASSESSMENT IN CHILD HEALTH CARE IN JAPAN
    Gai, R.
    VALUE IN HEALTH, 2017, 20 (05) : A62 - A63
  • [22] The role of public health epidemiology in the health technology assessment
    La Torre, Giuseppe
    Villari, Paolo
    Leyland, Alastair H.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2007, 17 : 50 - 50
  • [23] The need of a health technology assessment perspective in emergency medicine
    Iannone, Primiano
    EMERGENCY CARE JOURNAL, 2013, 9 (01) : 22 - 23
  • [24] Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective
    Kido, Kaori
    Matsumaru, Naoki
    Tsukamoto, Katsura
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (04) : 472 - 480
  • [25] A PERSPECTIVE ON THE USE OF HEALTH TECHNOLOGY ASSESSMENT IN BRAZIL AND MEXICO
    Stuwe, L. T.
    Bellanger, M. M.
    Panopoulou, G.
    Orci, S.
    Picon, P. D.
    Gadelha, M., I
    VALUE IN HEALTH, 2015, 18 (07) : A848 - A848
  • [26] PATIENT PERSPECTIVE IN HEALTH TECHNOLOGY ASSESSMENT OF PHARMACEUTICALS IN FINLAND
    Kleme, Jenni
    Pohjanoksa-Mantyla, Marika
    Airaksinen, Marja
    Enlund, Hannes
    Kastarinen, Helena
    Peura, Piia
    Hameen-Anttila, Katri
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (03) : 306 - 311
  • [27] HEALTH TECHNOLOGY ASSESSMENT OF DIABETES COMPOUNDS: THE POLISH PERSPECTIVE
    Adalsteinsson, J. E.
    Czech, M.
    Skrekowska-Baran, I
    Jasik, B. M.
    VALUE IN HEALTH, 2010, 13 (07) : A300 - A300
  • [28] Health technology assessment and policy from the economic perspective
    Rutten, F
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (01) : 67 - 70
  • [29] Pharmaceutical industry's perspective on health technology assessment
    Lothgren, M
    Ratcliffe, M
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2004, 20 (01) : 97 - 101
  • [30] ASSISTED REPRODUCTIVE TECHNOLOGIES: A HEALTH TECHNOLOGY ASSESSMENT PERSPECTIVE
    Hiller, J. E.
    Elshaug, A. G.
    Watt, A. M.
    Astute, S. G.
    VALUE IN HEALTH, 2010, 13 (07) : A546 - A546